STEMPOINT CAPITAL LP Hedge Fund

Location: New York, NY

CIK: 0001952142 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 13, 2024

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (43)

SNDX SYNDAX PHARMACEUTICALS INC 8.5%
Value $28.99M Shares 1,412,176 Est. Cost $16.60 Unrealized +26.1%
ROIV ROIVANT SCIENCES LTD 8.4%
Value $28.67M Shares 2,712,741 Est. Cost $10.15 Unrealized +8.0%
IMVT IMMUNOVANT INC 7.9%
Value $26.71M Shares 1,011,879 Est. Cost $33.53 Unrealized -15.2%
CRNX CRINETICS PHARMACEUTICALS IN 7.3%
Value $24.68M Shares 551,095 Est. Cost $35.72 Unrealized +29.3%
MERUS N V 5.0%
Value $17.08M Shares 288,668 Est. Cost $33.51 Unrealized
ACLX ARCELLX INC 4.6%
Value $15.49M Shares 280,709 Est. Cost $49.74 Unrealized +9.3%
FOLD AMICUS THERAPEUTICS INC 4.4%
Value $14.83M Shares 1,495,047 Est. Cost $11.99 Unrealized -14.4%
IMCR IMMUNOCORE HLDGS PLC 3.4%
Value $11.5M Shares 339,351 Est. Cost $33.89 Unrealized
APPLIED THERAPEUTICS INC 3.0%
Value $10.33M Shares 2,211,320 Est. Cost $5.20 Unrealized
MRK MERCK & CO INC 3.0%
Value $10.15M Shares 81,508 Est. Cost $121.72 Unrealized 0.0%
GSK GSK PLC 2.8%
Value $9.468M Shares 245,933 Est. Cost $38.50 Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 2.7%
Value $9.266M Shares 2,662,732 Est. Cost $6.39 Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 2.6%
Value $8.978M Shares 965,392 Est. Cost $2.72 Unrealized +232.7%
CABA CABALETTA BIO INC 2.6%
Value $8.812M Shares 1,178,105 Est. Cost $18.32 Unrealized -33.1%
KALV KALVISTA PHARMACEUTICALS INC 2.6%
Value $8.679M Shares 736,765 Est. Cost $11.79 Unrealized -1.0%
BHVN BIOHAVEN LTD 2.4%
Value $8.096M Shares 233,255 Est. Cost $36.52 Unrealized +8.3%
VTGN VISTAGEN THERAPEUTICS INC 1.7%
Value $5.848M Shares 1,848,582 Est. Cost $3.82 Unrealized +13.5%
IMTX IMMATICS N.V 1.7%
Value $5.836M Shares 502,207 Est. Cost $9.25 Unrealized +21.8%
DNLI DENALI THERAPEUTICS INC 1.7%
Value $5.828M Shares 251,010 Est. Cost $19.20 Unrealized 0.0%
INSM INSMED INC 1.7%
Value $5.828M Shares 86,980 Est. Cost $26.68 Unrealized +45.4%
CLDX CELLDEX THERAPEUTICS INC NEW 1.6%
Value $5.347M Shares 144,467 Est. Cost $37.73 Unrealized 0.0%
LRMR LARIMAR THERAPEUTICS INC 1.5%
Value $5.107M Shares 704,349 Est. Cost $3.37 Unrealized +127.0%
TCRX TSCAN THERAPEUTICS INC 1.5%
Value $4.944M Shares 845,069 Est. Cost $7.88 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 1.4%
Value $4.882M Shares 271,057 Est. Cost $17.44 Unrealized 0.0%
CRBP CORBUS PHARMACEUTICALS HLDGS 1.3%
Value $4.592M Shares 101,479 Est. Cost $42.06 Unrealized 0.0%
FULC FULCRUM THERAPEUTICS INC 1.3%
Value $4.318M Shares 696,464 Est. Cost $5.94 Unrealized +27.6%
NRIX NURIX THERAPEUTICS INC 1.2%
Value $4.242M Shares 203,273 Est. Cost $15.57 Unrealized 0.0%
PYXS PYXIS ONCOLOGY INC 1.2%
Value $3.981M Shares 1,202,675 Est. Cost $4.21 Unrealized -0.0%
JANX JANUX THERAPEUTICS INC 1.1%
Value $3.894M Shares 92,949 Est. Cost $21.78 Unrealized +115.6%
IDYA IDEAYA BIOSCIENCES INC 1.1%
Value $3.574M Shares 101,787 Est. Cost $42.52 Unrealized -6.9%
SYRE SPYRE THERAPEUTICS INC 1.0%
Value $3.537M Shares 150,450 Est. Cost $25.47 Unrealized +32.4%
CATX PERSPECTIVE THERAPEUTICS INC 1.0%
Value $3.428M Shares 343,810 Est. Cost $14.46 Unrealized 0.0%
JSPR JASPER THERAPEUTICS INC 1.0%
Value $3.264M Shares 143,775 Est. Cost $18.39 Unrealized +30.4%
BDTX BLACK DIAMOND THERAPEUTICS I 0.9%
Value $3.142M Shares 674,198 Est. Cost $5.37 Unrealized 0.0%
VIGIL NEUROSCIENCE INC 0.9%
Value $2.978M Shares 744,412 Est. Cost $4.00 Unrealized
NGNE NEUROGENE INC 0.8%
Value $2.86M Shares 78,601 Est. Cost $35.27 Unrealized 0.0%
SLN SILENCE THERAPEUTICS PLC 0.7%
Value $2.372M Shares 124,866 Est. Cost $19.00 Unrealized
TARA PROTARA THERAPEUTICS INC 0.6%
Value $2.047M Shares 984,113 Est. Cost $2.98 Unrealized -1.7%
BBOT HELIX ACQUISITION CORP II 0.6%
Value $2.044M Shares 200,000 Est. Cost $10.35 Unrealized -0.6%
SRZN SURROZEN INC 0.5%
Value $1.571M Shares 143,510 Est. Cost $10.32 Unrealized 0.0%
PCSC PERCEPTIVE CAP SOLUTIONS COR 0.4%
Value $1.509M Shares 150,000 Est. Cost $10.07 Unrealized 0.0%
PRAX PRAXIS PRECISION MEDICINES I 0.4%
Value $1.21M Shares 29,259 Est. Cost $45.06 Unrealized +4.9%
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.1%
Value $350K Shares 500,000 Est. Cost $2.72 Unrealized +232.7%